Literature DB >> 15125468

Coeliac disease in The Netherlands.

J J Schweizer1, B M E von Blomberg, H B Bueno-de Mesquita, M L Mearin.   

Abstract

BACKGROUND: The prevalence of adult coeliac disease in The Netherlands was studied in the Dutch Coeliac Disease Society and in blood donors but not in the general population. We therefore studied the prevalence of recognized and unrecognized coeliac disease in a large cohort, representative of the adult Dutch general population. Blood samples were available for anonymous research, as well as data on dietary habits, self-reported physical characteristics, health problems, quality of life and socio-economic circumstances.
METHODS: Subjects included 50,760 individuals who had previously participated in two large population-based studies on health status in relation to lifestyle factors. Recognized coeliac disease was studied in all subjects by identification of self-reported adherence to a gluten-free diet and subsequent confirmation of the diagnosis of coeliac disease. Unrecognized coeliac disease was studied in a random sample of 1440 out of the 50,760 subjects through serologic screening and human lymphocyte antigen (HLA) typing.
RESULTS: The prevalence of recognized coeliac disease was 0.016% (95% confidence interval 0.008-0.031) and of unrecognized coeliac disease 0.35% (95% confidence interval 0.15-0.81). Menarcheal age was higher in women with recognized coeliac disease than in women without coeliac disease.
CONCLUSIONS: The prevalence of adult recognized coeliac disease in The Netherlands is one of the lowest in Europe, while the prevalence of unrecognized coeliac disease is comparable with that in other European countries. Adult coeliac disease is strongly under diagnosed in The Netherlands. The higher menarcheal age in women with recognized coeliac disease may be explained by diagnostic delay.

Entities:  

Mesh:

Year:  2004        PMID: 15125468     DOI: 10.1080/00365520310008503

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.

Authors:  Reem Z Sharaiha; Ben Lebwohl; Laura Reimers; Govind Bhagat; Peter H Green; Alfred I Neugut
Journal:  Cancer       Date:  2011-12-13       Impact factor: 6.860

2.  Screening for coeliac disease in patients fulfilling the Rome II criteria for irritable bowel syndrome in a secondary care hospital in The Netherlands: a prospective observational study.

Authors:  Egbert-Jan van der Wouden; G Frits Nelis; Juda Vecht
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 4.  The spectrum of celiac disease: epidemiology, clinical aspects and treatment.

Authors:  Greetje J Tack; Wieke H M Verbeek; Marco W J Schreurs; Chris J J Mulder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-09       Impact factor: 46.802

Review 5.  Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy?

Authors:  N R Rosenberg; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

6.  Prevalence of celiac disease in Germany: a prospective follow-up study.

Authors:  Wolfgang Kratzer; Monika Kibele; Atilla Akinli; Marc Porzner; Bernhard O Boehm; Wolfgang Koenig; Suemeyra Oeztuerk; Richard A Mason; Ren Mao; Mark H Haenle
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

Review 7.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

8.  Outcome of Referrals for Non-Responsive Celiac Disease in a Tertiary Center: Low Incidence of Refractory Celiac Disease in the Netherlands.

Authors:  R L J van Wanrooij; G Bouma; H J Bontkes; A Neefjes-Borst; N C van Grieken; B M E von Blomberg; C J J Mulder
Journal:  Clin Transl Gastroenterol       Date:  2017-01-26       Impact factor: 4.488

9.  Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives.

Authors:  James C Barton; J Clayborn Barton
Journal:  J Immunol Res       Date:  2015-10-04       Impact factor: 4.818

10.  Testing for coeliac disease rarely leads to a diagnosis: a population-based study.

Authors:  Maxine D Rouvroye; Lotte Oldenburg; Pauline Slottje; Johanna H K Joosten; Renee X de Menezes; Marcel E Reinders; Gerd Bouma
Journal:  Scand J Prim Health Care       Date:  2021-06-17       Impact factor: 2.581

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.